Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Biosimilars and Pharmacovigilance: What’s Ahead

Posted on May 20th, 2016 by in Pharmacovigilance

DNA Magnification

DNA Magnification

In our first blog in this series, we drew from a recent IMS report  to demonstrate the market potential of biosimilars. Continue reading “Biosimilars and Pharmacovigilance: What’s Ahead” »

Biosimilars and Pharmacovigilance: What You Need to Know—and Do—Now

Posted on April 26th, 2016 by in Pharmacovigilance

A few weeks ago, the US FDA approved Inflectra (infliximab-dyyb), a biosimilar to infliximab. This is the second US biosimilar approval, suggesting others may soon be on the way—good news for companies with biosimilars pending approval and in development. Continue reading “Biosimilars and Pharmacovigilance: What You Need to Know—and Do—Now” »